Bit Bio, the new startup that pitches itself as the "enter button for the keyboard to the software of life," only needed three weeks to raise its latest $41.5 million round of funding. Originally ...

CAMBRIDGE, England, Dec. 2, 2025 /PRNewswire/ -- bit.b io, the global leader in cell programming technology, today announces the publication of its 2025 Corporate Sustainability Report, reaffirming ...

CAMBRIDGE, United Kingdom, Dec. 16, 2024 /PRNewswire/ -- bit.bio, the global leader in cell programming technology, today announced the successful closing of a $30 million financing round led by M&G ...

The consistency of the cells is enabling scientific breakthroughs and applications ranging from biohybrid devices, novel targets for neurodegeneration, and cultured meat. CAMBRIDGE, England & BOSTON-- ...

CAMBRIDGE, England, February 19, 2026--(BUSINESS WIRE)--Following a record Q4 in sales volume and the successful closing of $50 million in new funding, bit.bio is leveraging its economies of scale to ...

CAMBRIDGE, UK--(BUSINESS WIRE)--#Celltherapy--bit.bio, the company coding human cells for novel cures, today announced its cell therapy pipeline and declared its lead cell therapy candidate as it ...

Dr Hermann Hauser, serial entrepreneur, co-founder of Amadeus Capital Partners and founder of semiconductor company, Arm Ltd, and gene-sequencing company, Solexa / Illumina, joins as chair of the ...

The Cambridge University spinout combines coding and biology for its breakthrough Opti-ox technology that precisely reprograms stem cells, the type that are embryos for all the others, to make any ...

Bit Bio, the new startup that pitches itself as the “enter button for the keyboard to the software of life,” only needed three weeks to raise its latest $41.5 million round of funding. Originally ...

The report provides evidence-based metrics aligned with the UN Sustainable Development Goals (SDGs), highlighting year-over-year improvements. It demonstrates how sustainability is integrated across ...